Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 3 | GRO-a | 9054.0 | 55 | |
N2586 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | GRO-a | 8546.0 | 63 | |
N2586 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | GRO-a | 12156.0 | 50 | |
N2586 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | GRO-a | 3660.0 | 68 | |
N2586 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 3 | GRO-a | 5466.0 | 70 | |
N2586 | JNK-IN-11 | 0.3 | uM | 3 | GRO-a | 1697.5 | 56 | ||||
RA2159 | 3 | GRO-a | 5926.0 | 63 | |||||||
RA2159 | PD184352 | 0.1 | uM | 3 | GRO-a | 2746.0 | 53 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | GRO-a | 3635.0 | 53 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | GRO-a | 6284.0 | 61 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | GRO-a | 5864.0 | 55 | ||||
RA2159 | IKK16 | 2.0 | uM | 3 | GRO-a | 2876.5 | 66 | ||||
RA2159 | JNK-IN-8 | 3.0 | uM | 3 | GRO-a | 1653.0 | 72 | ||||
N2586 | 3 | GRO-a | 9790.5 | 70 | |||||||
N2586 | PD184352 | 0.1 | uM | 3 | GRO-a | 7110.0 | 63 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 3 | GRO-a | 6641.0 | 71 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 3 | GRO-a | 9516.0 | 69 | ||||
N2586 | Tofacitinib | 0.3 | uM | 3 | GRO-a | 2905.0 | 59 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | GRO-a | 4049.0 | 61 | ||||
N2586 | JNK-IN-8 | 3.0 | uM | 3 | GRO-a | 6615.0 | 69 | ||||
RA2159 | IL-17A | 100 | ng/mL | 3 | GRO-a | 13140.5 | 64 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | GRO-a | 7726.0 | 71 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | GRO-a | 16443.0 | 67 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | GRO-a | 14747.0 | 61 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | GRO-a | 14614.0 | 72 |